Sort
21,281 grants matching “influenza”
Evaluating School-Based Influenza Vaccination Programs that Bill Health Insurance
$300,000Judith C Shlay · Denver Health And Hospital Authority · U01 · FY2008 · IP
Novel Protein Adjuvant for Flu Vaccines
$300,000Jiu Jiang · Dmx, Inc. · R43 · FY2010 · AI
Immune Dampening the OMPs of non-typeable H. influenzae
$300,000Biological Mimetics, Inc. · R43 · FY2003 · AI
Small molecule inhibitors of influenza virus nucleoprotein
$300,000Daniel A Engel · Alexander Biodiscoveries, Llc · R41 · FY2021 · AI
Enhanced Seasonal Influenza Vaccine Targeting Variable and Conserved Antigens
$300,000Kenneth C Bagley · Orlance, Inc. · R44 · FY2024 · AI
Targeted RNA degradation assay for new antiviral drug discovery
$300,000Ryan O'Hanlon · Lucerna, Inc. · R43 · FY2024 · AI
Adjuvant-containing chimeric virus-like particles as improved influenza vaccines
$299,999Fu Shi Quan · Zetra Biologicals, Llc · R43 · FY2009 · AI
Development of group 2 influenza A virus entry inhibitors
$299,999Lijun Rong · Chicago Biosolutions, Inc. · R41 · FY2019 · AI
Virus-like particle vaccines against respiratory syncytial virus
$299,999Fu Shi Quan · Zetra Biologicals, Llc · R43 · FY2010 · AI
EAGER: Engineered nano-scale barrier to prevent viral infections
$299,999Mark S Humayun · University Of Southern California · · FY2020 · ENG
A New Approach to Phylogenetic Analysis Using Structural Information
$299,999Abel Rodriguez · University Of California Santa Cruz · R01 · FY2009 · GM
Immune Dampening the OMPs of non-typeable H. influenzae
$299,999Biological Mimetics, Inc. · R43 · FY2004 · AI
New target and new therapy for severe Covid-19 and viral hyperinflammation damage: renalase and renalase agonists
$299,999Barry A Berkowitz · Bessor Pharma, Llc · R43 · FY2023 · AI
Reverse Line Blot Assay for Trypanosome and Leishmania Detection and Identificati
$299,999Andrew E. Levin · Immunetics, Inc. · R43 · FY2011 · AI
Novel, Self-Applied MicroArray Patch (MAP) of Zanamivir for Treatment of the Flu
$299,999Elke Lipka · Tsrl, Inc. · R44 · FY2023 · AI
Virus-like particle vaccines against respiratory syncytial virus
$299,999Young Man Kwon · Zetra Biologicals, Llc · R43 · FY2011 · AI
Adjuvant-containing chimeric virus-like particles as improved influenza vaccines
$299,999Fu Shi Quan · Zetra Biologicals, Llc · R43 · FY2010 · AI
Screening for rAAV transduction enhancers
$299,999Terry L Bowlin · Microbiotix, Inc · R43 · FY2017 · AI
Development of group 2 influenza A virus entry inhibitors
$299,999Lijun Rong · Chicago Biosolutions, Inc. · R41 · FY2020 · AI
Reverse Line Blot Assay for Trypanosome and Leishmania Detection and Identificati
$299,999Andrew E. Levin · Immunetics, Inc. · R43 · FY2010 · AI
A novel antibody therapy for Sin Nombre virus infection
$299,998Michael W Fanger · Celdara Medical, Llc · R43 · FY2019 · AI
Proof-of-Principle Studies of DAS181 for Parainfluenza Virus Infection
$299,998Fang Fang · Nexbio, Inc. · R43 · FY2010 · AI
Surrogate endpoints for correlating protective immunity in response to influenza
$299,994Gary Fujii · Molecular Express, Inc. · R43 · FY2010 · AI
IMMUNOGENICITY TESTING OF A FULLY SYNTHETIC SUBUNIT VACCINE AGAINST INFLUENZA
$299,994Catherine H Charles · Medivas, Llc · R43 · FY2007 · AI
Sparse Sensing, Actuation, and Communication in Complex Networks
$299,987Milad Siami · Northeastern University · · FY2021 · ENG